A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.

<h4>Background</h4>Alzheimer's disease (AD) is a devastating public health problem that affects over 5.4 million Americans. Depression increases the risk of Mild Cognitive Impairment (MCI) and AD. By understanding the influence of depression on cognition, the potential exists to ide...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leigh A Johnson, James R Hall, Sid E O'Bryant
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/190e0e64957b4064a108a5d4ad7185dc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:190e0e64957b4064a108a5d4ad7185dc
record_format dspace
spelling oai:doaj.org-article:190e0e64957b4064a108a5d4ad7185dc2021-11-18T07:37:48ZA depressive endophenotype of mild cognitive impairment and Alzheimer's disease.1932-620310.1371/journal.pone.0068848https://doaj.org/article/190e0e64957b4064a108a5d4ad7185dc2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874786/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Alzheimer's disease (AD) is a devastating public health problem that affects over 5.4 million Americans. Depression increases the risk of Mild Cognitive Impairment (MCI) and AD. By understanding the influence of depression on cognition, the potential exists to identify subgroups of depressed elders at greater risk for cognitive decline and AD. The current study sought to: 1) clinically identify a sub group of geriatric patients who suffer from depression related cognitive impairment; 2) cross validate this depressive endophenotype of MCI/AD in an independent cohort.<h4>Methods and findings</h4>Data was analyzed from 519 participants of Project FRONTIER. Depression was assessed with the GDS30 and cognition was assessed using the EXIT 25 and RBANS. Five GDS items were used to create the Depressive endophenotype of MCI and AD (DepE). DepE was significantly negatively related to RBANS index scores of Immediate Memory (B=-2.22, SE=.37, p<0.001), visuospatial skills (B=-1.11, SE=0.26, p<0.001), Language (B=-1.03, SE=0.21, p<0.001), Attention (B=-2.56, SE=0.49, p<0.001), and Delayed Memory (B=-1.54, SE = 037, p<0.001), and higher DepE scores were related to poorer executive functioning (EXIT25; B=0.65, SE=0.19, p=0.001). DepE scores significantly increased risk for MCI diagnosis (odds ratio [OR] = 2.04; 95% CI=1.54-2.69). Data from 235 participants in the TARCC (Texas Alzheimer's Research & Care Consortium) were analyzed for cross-validation of findings in an independent cohort. The DepE was significantly related to poorer scores on all measures, and a significantly predicted of cognitive change over 12- and 24-months.<h4>Conclusion</h4>The current findings suggest that a depressive endophenotype of MCI and AD exists and can be clinically identified using the GDS-30. Higher scores increased risk for MCI and was cross-validated by predicting AD in the TARCC. A key purpose for the search for distinct subgroups of individuals at risk for AD and MCI is to identify novel treatment and preventative opportunities.Leigh A JohnsonJames R HallSid E O'BryantPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e68848 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Leigh A Johnson
James R Hall
Sid E O'Bryant
A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
description <h4>Background</h4>Alzheimer's disease (AD) is a devastating public health problem that affects over 5.4 million Americans. Depression increases the risk of Mild Cognitive Impairment (MCI) and AD. By understanding the influence of depression on cognition, the potential exists to identify subgroups of depressed elders at greater risk for cognitive decline and AD. The current study sought to: 1) clinically identify a sub group of geriatric patients who suffer from depression related cognitive impairment; 2) cross validate this depressive endophenotype of MCI/AD in an independent cohort.<h4>Methods and findings</h4>Data was analyzed from 519 participants of Project FRONTIER. Depression was assessed with the GDS30 and cognition was assessed using the EXIT 25 and RBANS. Five GDS items were used to create the Depressive endophenotype of MCI and AD (DepE). DepE was significantly negatively related to RBANS index scores of Immediate Memory (B=-2.22, SE=.37, p<0.001), visuospatial skills (B=-1.11, SE=0.26, p<0.001), Language (B=-1.03, SE=0.21, p<0.001), Attention (B=-2.56, SE=0.49, p<0.001), and Delayed Memory (B=-1.54, SE = 037, p<0.001), and higher DepE scores were related to poorer executive functioning (EXIT25; B=0.65, SE=0.19, p=0.001). DepE scores significantly increased risk for MCI diagnosis (odds ratio [OR] = 2.04; 95% CI=1.54-2.69). Data from 235 participants in the TARCC (Texas Alzheimer's Research & Care Consortium) were analyzed for cross-validation of findings in an independent cohort. The DepE was significantly related to poorer scores on all measures, and a significantly predicted of cognitive change over 12- and 24-months.<h4>Conclusion</h4>The current findings suggest that a depressive endophenotype of MCI and AD exists and can be clinically identified using the GDS-30. Higher scores increased risk for MCI and was cross-validated by predicting AD in the TARCC. A key purpose for the search for distinct subgroups of individuals at risk for AD and MCI is to identify novel treatment and preventative opportunities.
format article
author Leigh A Johnson
James R Hall
Sid E O'Bryant
author_facet Leigh A Johnson
James R Hall
Sid E O'Bryant
author_sort Leigh A Johnson
title A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
title_short A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
title_full A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
title_fullStr A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
title_full_unstemmed A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
title_sort depressive endophenotype of mild cognitive impairment and alzheimer's disease.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/190e0e64957b4064a108a5d4ad7185dc
work_keys_str_mv AT leighajohnson adepressiveendophenotypeofmildcognitiveimpairmentandalzheimersdisease
AT jamesrhall adepressiveendophenotypeofmildcognitiveimpairmentandalzheimersdisease
AT sideobryant adepressiveendophenotypeofmildcognitiveimpairmentandalzheimersdisease
AT leighajohnson depressiveendophenotypeofmildcognitiveimpairmentandalzheimersdisease
AT jamesrhall depressiveendophenotypeofmildcognitiveimpairmentandalzheimersdisease
AT sideobryant depressiveendophenotypeofmildcognitiveimpairmentandalzheimersdisease
_version_ 1718423144906096640